Additional discussion needed before final decision made in publication of bird flu studies Attendees of a recently available WHO conference that discussed the possible publication in the journals Character and Science of two studies that modified H5N1 bird flu strains to show the virus could possibly be easier transmissible among humans decided publication of redacted versions would be ineffective and that ‘a system for distributing the full paper only to selected individuals would be impossible to set up on any relevant timescale,’ a Nature editorial states. Participants also learned ‘not merely does the mammalian transmissibility threat seem higher than previously believed, but also that current avian viruses have a few of the mutations identified in the new work,’ according to the editorial.However, since this is a crossover trial, these differences must have had minimal effects on the total results. In 20 percent of the patients with the metabolic syndrome who underwent CPAP therapy, the metabolic syndrome resolved within 3 months, which is a clinically significant improvement. Nevertheless, the reversal of the metabolic syndrome was usually because of a significant reduction in only 1 of the components, with no particular element driving this impact. A randomized crossover trial by Coughlin and colleagues8 of a previously studied human population didn’t show a significant decrease in the prevalence of the metabolic syndrome after 6 weeks of CPAP therapy, whereas an uncontrolled trial17 showed a substantial decline in the prevalence of the metabolic syndrome after 6 months.